Human IgA2 Isotype Control Antibody (13R4)

Catalog No.

FHJ92510

Host species

Human

Isotype

IgA2, kappa

Clonality

Monoclonal

Conjugation

Unconjugated

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Applications

FCM, Isotype Control, In vivo Control

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

13R4

IgA autoimmunity and coagulation among post-acute sequelae of SARS-CoV-2 infection (PASC) patients with persistent respiratory symptoms: a case-control study., PMID:40519899

IgA Antibodies to Bovine Serum Albumin in Adult Patients with Celiac Disease., PMID:40507813

Lactoferrin and SIgA Concentrations in Human Milk of SARS-CoV-Infected Mothers-Polish Cohort Study., PMID:40507109

Uniting against enteric invaders: IgA meets its microbial ally., PMID:40505624

Profiling of Anti-glycan IgA and IgG in Oral Fluid Using a Glycan Microarray., PMID:40498306

Serological analysis of gluten-related antibodies in idiopathic neuropathies and cerebellar ataxia., PMID:40481865

Exploring the standardized detection and sampling methods of human nasal SARS-CoV-2 RBD IgA., PMID:40463384

A Nasal Vaccine Displaying Anthrax Antigen on the Surface of Lactiplantibacillus plantarum Induces Protective Mucosal Immunity against Anthrax Toxin., PMID:40443240

Chlamydia muridarum mutant CM-pGP3S as a novel attenuated live rectal vaccine protects against genital tract infection., PMID:40433661

Individuals Infected with SARS-CoV-2 Prior to COVID-19 Vaccination Maintain Vaccine-Induced RBD-Specific Antibody Levels and Viral Neutralization Activity for One Year., PMID:40431652

Integrated in-silico design and in vivo validation of multi-epitope vaccines for norovirus., PMID:40426240

Characterizing local antibody responses in the muscle of inclusion body myositis patients., PMID:40424896

PcrV in an intranasal adjuvanted tobacco mosaic virus conjugate vaccine mediates protection from Pseudomonas aeruginosa via an early Th1/Th17 skewed localized and systemic immune response., PMID:40424705

Construction of a variable fragment (Fv)-immunoglobulin A (IgA) anti-receptor binding domain (RBD) SARS-CoV-2 library based on IgA from Indonesian COVID-19 survivors., PMID:40403817

Establishment of a novel adjuvant screening system for the development of intranasal vaccine adjuvants., PMID:40383081

An oral norovirus vaccine generates mucosal immunity and reduces viral shedding in a phase 2 placebo-controlled challenge study., PMID:40367195

Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in mice., PMID:40360777

Binding antibody titers against the hemagglutinin and neuraminidase correlate with protection against medically attended influenza A and B disease., PMID:40358209

Intranasal vaccination with multi-neuraminidase and M2e virus-like particle vaccine results in greater mucosal immunity and protection against influenza than intramuscular injection., PMID:40339180

Comprehensive analysis of nasal IgA antibodies induced by intranasal administration of the SARS-CoV-2 spike protein., PMID:40338637

Dynamics of IgM and IgA Antibody Response Profile Against Vibrio cholerae Toxins A, B, and P., PMID:40331989

Intestinal mucosal immune responses induced by novel oral poliovirus vaccine type 2 and Sabin monovalent oral poliovirus vaccine type 2: an analysis of data from four clinical trials., PMID:40318674

Tph cells are expanded in IgA vasculitis nephritis., PMID:40315784

Increased serum levels of IL-40 are associated with IgA and NETosis biomarkers in Covid-19 patients: IL-40 and infectious diseases., PMID:40315230

An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse models., PMID:40312392

Mucosal immune responses to SARS-CoV-2 infection and COVID-19 vaccination., PMID:40311214

Enrichment of human IgA-coated bacterial vesicles in ulcerative colitis as a driver of inflammation., PMID:40301356

Dietary supplementation with Nopalea cochenillifera enhances fecal mucin production and modulates serum immunoglobulin levels in a dose- and time-dependent manner in BALB/c mice., PMID:40301082

Unravelling the Impact of Outer Membrane Protein, OmpA, From S. Typhimurium on Aberrant AID Expression and IgM to IgA Class Switching in Human B-Cells., PMID:40300848

Exhausted natural killer cells in adult IgA vasculitis., PMID:40269956

Shigella humoral immunity during the first 2 years of life in children from endemic areas., PMID:40237475

Protein-specific immune response elicited by the Shigella sonnei 1790GAHB GMMA-based candidate vaccine in adults with varying exposure to Shigella., PMID:40237462

Circulating Food Allergen-Specific Antibodies, Beyond IgG4, Are Elevated in Eosinophilic Esophagitis., PMID:40230181

Robust immune responses to intranasal vaccine targeting Bordetella pertussis antigens to claudin-4 on mucosal microfold cells., PMID:40220802

Early-life gut microbiome associates with positive vaccine take and shedding in neonatal schedule of the human neonatal rotavirus vaccine RV3-BB., PMID:40210877

Mucosal stargazing: IgA keeps astrovirus in check., PMID:40209671

Clinical characteristics and immunotherapy efficacy in autoimmune-associated benign epilepsy with centrotemporal spikes: A prospective cohort study., PMID:40209515

Deciphering N-Glycosylation Dynamics of Serum Monoclonal Immunoglobulins in Multiple Myeloma via EThcD-sceHCD-MS/MS., PMID:40204705

Differential gut microbiota and inflammatory cytokines contribute to IgA vasculitis., PMID:40201970

Serum anti-lipid antibodies in patients affected by leprosy in a high-burden municipality in Brazil: a cross-sectional study., PMID:40197967

Exploring TLR agonists as adjuvants for COVID-19 oral vaccines., PMID:40184639

VP4-Specific IgA level as a correlate of neutralizing antibody and fecal shedding of porcine rotavirus infection., PMID:40179488

Direct immunofluorescence of labial gland in diagnosis of Sjögren's disease., PMID:40172814

CSF Markers of TG6 Autoimmunity in Gluten Ataxia., PMID:40172737

Virus-specific antibody responses in severe acute respiratory syndrome coronavirus 2-infected and vaccinated individuals., PMID:40157431

Glycoproteomics of IgA1: uncovering key N-glycan composition in ankylosing spondylitis., PMID:40156295

Immunoglobulin A controls intestinal virus colonization to preserve immune homeostasis., PMID:40154490

Fecal Secretory Immunoglobulin A and Lactate Level as a Biomarker of Mucosal Immune Dysfunction in Horses With Colic., PMID:40145309

Broad Mucosal and Systemic Immunity in Mice Induced by Intranasal Booster With a Novel Recombinant Adenoviral Based Vaccine Protects Against Divergent Influenza A Virus., PMID:40145257

Music of Different Tones Maintains Intestinal Immunity by Regulating the Intestinal Barrier and Intestinal Microbiota., PMID:40141126

Document Download

Human IgA2 Isotype Control Antibody (13R4).pdf